SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.85-0.1%3:35 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert K. who wrote (8521)1/28/1999 11:43:00 AM
From: aknahow  Read Replies (3) of 17367
 
If XOMA resorts to a floorless convertible I will seek out a class action lawyer. Not a threat. A simple statement of fact. There is no real or meaningful protection that can be built in.

There are other methods of financing. They have tried the floorless convertibles and while at times it has worked it has not been good for XOMA as a whole.

Let them know you think the idea sucks, if you think it does.

Also, when the trial ends and XOMA knows the total number of deaths, this information should be released to shareholders. I do understand that the unblinded information is not released for 10 days for deaths and a full 90 days for all endpoints. I expect unblinded information on deaths when XOMA has it. There is no reason to not release it as others will have it and be able to trade on their information.

BTW what is your source, i.e. trigger for the above.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News